“…Besides, clinical characteristics among VCX3A and HCC in TCGA also showed that high expression of VCX3A was more likely to cause vascular invasion in HCC patients (Table 1). Identifying hsa-miR-664a-3p-VCX3A axis play a key role in HCC First, we predicted upstream miRNAs of VCX3A through TargetScan, miRWalk and miRDB three databases, since increasing studies have indicated that miRNAs take part in the invasion and metastasis of multiple tumors and play signi cant functions in cancer development [15][16][17]. As presented in Figure 4A-B, a total of 15 miRNAs (hsa-miR-2861, hsa-miR-5739, hsa-miR-4505, hsa-miR-6770-3p, hsa-miR-7855-5p, hsa-miR-4299, hsa-miR-6871-3p, hsa-miR-31-5p, hsa-miR-181a-5p, hsa-miR-450b-5p, hsa-miR-3615, hsa-miR-5696, hsa-miR-664b-3p, hsa-miR-579-3p, hsa-miR-664a-3p) appeared twice or more than twice in three predicting databases were selected for the further analysis.…”